News Daily News TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows Michael O'Riordan July 17, 2017
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Daily News Simple Frailty Test in TAVR Can Help Decide Not Just ‘If’ but ‘How’ Shelley Wood July 07, 2017
News Daily News Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR Alison Palkhivala July 07, 2017
News Daily News Higher BMI Linked to Increased Risk of CHD, Hypertension, and Diabetes Michael O'Riordan July 06, 2017
News Daily News More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis Michael O'Riordan July 03, 2017
News Daily News TAVR Use Triples in France, With Docs Treating Lower-Risk Patients Michael O'Riordan June 26, 2017
News Daily News One in 10 TAVR Patients Treated Off-Label: TVT Registry Michael O'Riordan June 22, 2017
News Daily News Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions Michael O'Riordan June 06, 2017
News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Daily News Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes Shelley Wood May 02, 2017
News Daily News Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests Caitlin E. Cox April 21, 2017
News Daily News Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care Yael L. Maxwell April 14, 2017
News Daily News Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction Shelley Wood April 13, 2017
News Daily News Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3 L.A. McKeown April 12, 2017
News Daily News SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation Yael L. Maxwell April 04, 2017
News Daily News Boston Scientific Adds Two More TAVR Valves With Symetis Purchase Michael O'Riordan March 30, 2017